Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-25T15:16:18.432Z Has data issue: false hasContentIssue false
  • English
  • Français

Comments to Dr. H. Petit's Communication on Refsum's Disease and Refsum's Syndrome

Published online by Cambridge University Press:  01 August 2014

Sigvald Refsum
Sigvald Refsum*
Affiliation:
Department of Neurology, University of Oslo, Norway
*
Neurologisk Avdeling, Rikshospitalet, Oslo 1, Norway

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The difference between the two clinical pictures, heredopathia atactica polyneuritiformis and “Refum's syndrome” is stressed, together with their individual variability. A review of the literature clearly shows that in none of the cases of “Refsum's syndrome” described so far have any biochemical errors been identified.

The cases with a symptomatology similar to heredopathia atactica polyneuritiformis represent a challenge to further intensive studies.

Type
8. Free Contributions: Fourth Group
Information
Acta geneticae medicae et gemellologiae: twin research , Volume 23 , supplement S1 , January 1974 , pp. 333 - 335
Copyright
Copyright © The International Society for Twin Studies 1974

References

REFERENCES

Baum, J.L. Tannenbaum, M. Kolodny, E.H. 1965. Refsum's syndrome with corneal involvement. Am. J. Ophthalmol., 66: 699–708.CrossRefGoogle Scholar
Eldjarn, L., Try, K., Stokke, O., Munthe-Kaas, A.W., Refsum, S., Steinberg, D., Avigan, J., Mize, C. 1966. Dietary effects on serum-phytanic acid levels and on clinical manifestations in heredopathia atactica polyneuritiformis. Lancet, 1: 691–693.Google Scholar
Eldjarn, L., Refsum, S., Stokke, O., Try, K. 1973. Heredopathia atactica polyneuritiformis. Dietary treatment and pathogenetic role of phytanic acid. Excerpta Medica, Int. Congr. Ser. No. 296, p. 127.Google Scholar
Gautier, J.C., Laudat, Ph., Rosa, A., Gray, F., Lhermitte, F. 1973. Maladie de Refsum. Test de charge en phytol chez un descendant. Nouv. Presse Med., 2: 2029–2032.Google Scholar
Kayden, H.J., Reagan, T.J., Mize, C.E., Herndon, J.H. Jr., Steinberg, D. 1973. Diffuse cerebral sclerosis. Erroneously reported as Refsum's syndrome. Arch. Neurol., 28: 304–307.CrossRefGoogle ScholarPubMed
Kolodny, E.H., Hass, W.K., Lane, B., Drucker, W.D. 1965. Refsum's syndrome. Report of a case including electron microscopic studies of the liver. Arch. Neurol., 12: 583–596.Google Scholar
Refsum, S. 1974. Heredopathia atactica polyneuritiformis. Phytanic acid storage disease (Refsum's disease). In Vinken, and Bruyn, (eds.). Handbook of Clinical Neurology, Vol. 21 (in print).Google Scholar
Skre, H., Eldjarn, L., Stokke, O., Try, K. 1969. A new case of heredopathia atactica polyneuritiformis (Refsum's disease). A review with special emphasis on dietary treatment. Excerpta Medica, Int. Congr. Series No. 175, pp. 710–722.Google Scholar
Solcher, H. 1973. Ueber Hirnveranderungen bei Heredopathia atactica polyneuritiformis (Refsum). Acta Neuropathol. (Berl.), 24: 92–95.Google Scholar
Try, K. 1969. Heredopathia atactica polyneuritiformis (Refsum's disease). The diagnostic value of phytanic acid determination in serum lipids. Eur. Neurol., 2: 296–314.Google Scholar